First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer

First patients dosed in OPTIMAL-e1 Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent’s Hospital ...
Bloomberg L.P.

New Therapeutic Options Could Shift Prostate Cancer Treatment (APAC)

We will discuss the current prostate cancer treatments and key catalysts for older drugs facing loss of exclusivity. We will also discuss new therapies for prostate cancer, with protein degraders and ...
New York Post

This cancer often has no warning signs — a pioneering new treatment freezes it away

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...
Cure Today

Making the Most of My 'Watching and Waiting' for Prostate Cancer

During my "watch and wait" time for prostate cancer, I spend this time wisely on things like attending writing webinars. As a patient with prostate cancer, I’ve grown used to hearing my doctor say, ...
Bloomberg L.P.

New Therapeutic Options Could Shift Prostate Cancer Treatment

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. By submitting this information, I agree to the privacy policy and to learn more about ...